Vancomycin Resistant Enterococci Infection: Clinical Trials

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	1	Recruiting 1
Phase 3	1	Recruiting 1

Follow Vancomycin Resistant Enterococci Infection: new trials by email Literature Review of Vancomycin Resistant Enterococci Infection trials Research Report on Vancomycin Resistant Enterococci Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients Vancomycin 125mg, Placebo - Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection	Phase 2 / Phase 3	Recruiting	Riverside University Health System Medical Center	176	2024-10-21	2025-11-10

Narrower conditions

Clostridium Infections (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)

Interventions

Vancomycin (1)

Sponsors

Riverside University Health System Medical Center (1)

Countries

United States (1)